Eliquis (apixaban) available at more than 40 per cent discount; Sotyktu to be offered at more than 80 per cent discount to current list price
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
Real-world and long-term extension data, including updated results from post-launch evaluation of REMS Program, bolster growing body of evidence supporting the efficacy and safety profile of CAMZYOS
He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
New analyses, including presentations on mavacamten, apixaban and milvexian, further solidify the company's strength and expertise as a leader in cardiovascular diseases
Subscribe To Our Newsletter & Stay Updated
